{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:52:59Z","timestamp":1793321579286,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["EU-MASCARA HEALTH, 2011.2.4.2-2"],"award-info":[{"award-number":["EU-MASCARA HEALTH, 2011.2.4.2-2"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PS09\/02014, SAF2011-23029 and PI 12\/02615 and the Strategic Action for Research in Health sciences [CP12\/03080, PI10\/0082, PI13\/01848, PI11\/00726, PI16\/01402]"],"award-info":[{"award-number":["PS09\/02014, SAF2011-23029 and PI 12\/02615 and the Strategic Action for Research in Health sciences [CP12\/03080, PI10\/0082, PI13\/01848, PI11\/00726, PI16\/01402]"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CIBERObn) [CIBER-02-08-2009, CB06\/03 and CB12\/03\/30016]"],"award-info":[{"award-number":["CIBER Fisiopatolog\u00eda Obesidad y Nutrici\u00f3n (CIBERObn) [CIBER-02-08-2009, CB06\/03 and CB12\/03\/30016]"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0914-1","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:24:00Z","timestamp":1536013440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study"],"prefix":"10.1186","volume":"18","author":[{"name":"on behalf of the ESCARVAL STUDY GROUP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Navarro-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Orozco-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Gil-Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Valls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Perez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Dominguez-Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Martin-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-6773","authenticated-orcid":false,"given":"Josep","family":"Redon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tellez-Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"914_CR1","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00394-016-1212-2","volume":"55","author":"GB Stefano","year":"2016","unstructured":"Stefano GB, Challenger S, Kream RM. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders. Eur J Nutr. 2016;55:2339\u201345.","journal-title":"Eur J Nutr"},{"issue":"1S","key":"914_CR2","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.amjcard.2017.05.015","volume":"120","author":"F Paneni","year":"2017","unstructured":"Paneni F, L\u00fcscher TF. Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. Am J Cardiol. 2017;120(1S):S17\u201327.","journal-title":"Am J Cardiol"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.dsx.2014.04.037","volume":"8","author":"S Camara","year":"2014","unstructured":"Camara S, Bouenizabila E, Hermans MP, Ahn SA, Rousseau MF. Novel determinants preventing achievement of major cardiovascular targets in type 2 diabetes. Diabetes Metab Syndr. 2014;8:145\u201351.","journal-title":"Diabetes Metab Syndr"},{"key":"914_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12872-016-0231-5","volume":"16","author":"A Eranti","year":"2016","unstructured":"Eranti A, Kerola T, Aro AL, Tikkanen JT, Rissanen HA, Anttonen O, Junttila MJ, Knekt P, Huikuri HV. Diabetes, glucose tolerance, and the risk of sudden cardiac death. BMC Cardiovasc Disord. 2016;16:51.","journal-title":"BMC Cardiovasc Disord"},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12872-016-0331-2","volume":"16","author":"H Liang","year":"2016","unstructured":"Liang H, Guo YC, Chen LM, Li M, Han WZ, Zhang X, Jiang SL. Relationship between fasting glucose levels and in-hospital mortality in Chinese patients with acute myocardial infarction and diabetes mellitus: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16:156.","journal-title":"BMC Cardiovasc Disord"},{"key":"914_CR6","doi-asserted-by":"publisher","first-page":"e1525","DOI":"10.1097\/MD.0000000000001525","volume":"94","author":"WI Liao","year":"2015","unstructured":"Liao WI, Wang JC, Chang WC, Hsu CW, Chu CM, Tsai SH. Usefulness of glycemic gap to predict ICU mortality in critically ill patients with diabetes. Medicine (Baltimore). 2015;94:e1525.","journal-title":"Medicine (Baltimore)"},{"key":"914_CR7","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","volume":"52","author":"FM Turnbull","year":"2009","unstructured":"Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288\u201398.","journal-title":"Diabetologia"},{"key":"914_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.4093\/dmj.2011.35.5.551","volume":"35","author":"HG Oh","year":"2011","unstructured":"Oh HG, Rhee EJ, Kim TW, Lee KB, Park JH, Yang KI, Jeong D, Park HK. Higher glycated hemoglobin level is associated with increased risk for ischemic stroke in non-diabetes korean male adults. Diabetes Metab J. 2011;35:551\u20137.","journal-title":"Diabetes Metab J"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1006524","volume":"364","author":"HC Gerstein","year":"2011","unstructured":"ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818\u201328.","journal-title":"N Engl J Med"},{"key":"914_CR10","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in pa- tients with type 2 diabetes. N Engl J Med. 2008;358:2560\u201372.","journal-title":"N Engl J Med"},{"key":"914_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, Investigators VADT. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129\u201339.","journal-title":"N Engl J Med"},{"key":"914_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00125-005-1858-4","volume":"48","author":"HC Gerstein","year":"2005","unstructured":"Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S. HOPE investigators. The relationship between dysglycaemia and cardiovascular and renal risk in diabetes and non-diabetes participants in the HOPE study: a prospective epidemiological analysis. Diabetologia. 2005;48:1749\u201355.","journal-title":"Diabetologia"},{"key":"914_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0908359","volume":"362","author":"E Selvin","year":"2010","unstructured":"Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetes adults. N Engl J Med. 2010;362:800\u201311.","journal-title":"N Engl J Med"},{"key":"914_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jama.2014.1873","volume":"311","author":"E Di Angelantonio","year":"2014","unstructured":"Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Nj\u00f8lstad I, Nissinen A, Brunner EJ, Kuller LH, Price JF, Sundstr\u00f6m J, Knuiman MW, Feskens EJ, Verschuren WM, Wald N, Bakker SJ, Whincup PH, Ford I, Goldbourt U, G\u00f3mez-de-la-C\u00e1mara A, Gallacher J, Simons LA, Rosengren A, Sutherland SE, Bj\u00f6rkelund C, Blazer DG, Wassertheil-Smoller S, Onat A, Mar\u00edn Iba\u00f1ez A, Casiglia E, Jukema JW, Simpson LM, Giampaoli S, Nordestgaard BG, Selmer R, Wennberg P, Kauhanen J, Salonen JT, Dankner R, Barrett-Connor E, Kavousi M, Gudnason V, Evans D, Wallace RB, Cushman M, D\u2019Agostino RB Sr, Umans JG, Kiyohara Y, Nakagawa H, Sato S, Gillum RF, Folsom AR, van der Schouw YT, Moons KG, Griffin SJ, Sattar N, Wareham NJ, Selvin E, Thompson SG, Danesh J. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014;311:1225\u201333.","journal-title":"JAMA"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all-cause mortality: systematic review and meta-analysis. BMJ. 2016 Nov 23;355:i5953.","journal-title":"BMJ"},{"key":"914_CR16","doi-asserted-by":"crossref","unstructured":"Rodkey GV. Electronic Health Records. New Engl J Med. 2010;363:2372\u20134.","DOI":"10.1056\/NEJMc1010028"},{"key":"914_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/1471-2458-10-717","volume":"10","author":"V Gil-Guillen","year":"2010","unstructured":"Gil-Guillen V, Orozco-Beltran D, Redon J, Pita-Fernandez S, Navarro-P\u00e9rez J, Pallares V, Valls F, Fluixa C, Fernandez A, Martin-Moreno JM, Pascual-de-la-Torre M, Trillo JL, Durazo-Arvizu R, Cooper R, Hermenegildo M, Rosado L. Rationale and methods of the cardiometabolic Valencian study (Escarval-risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia. BMC Public Health. 2010;10:717.","journal-title":"BMC Public Health"},{"key":"914_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/HJH.0000000000000930","volume":"34","author":"J Redon","year":"2016","unstructured":"Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-P\u00e9rez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Sanz G, Martin-Moreno JM, ESCARVAL Study Group. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study. J Hypertens. 2016;34:1075\u201383.","journal-title":"J Hypertens"},{"key":"914_CR19","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1097\/HJH.0000000000001089","volume":"34","author":"M Tellez-Plaza","year":"2016","unstructured":"Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita-Fernandez S, Navarro-P\u00e9rez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J, ESCARVAL STUDY GROUP. Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio cardiovascular Valencia-risk study. J Hypertens. 2016;34:2266\u201373.","journal-title":"J Hypertens"},{"key":"914_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, Sans S, Menotti A, De backer G, De Bacquer D, Ducimeti\u00e8re P, Jousilahti P, Keil U, Nj\u00f8lstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987\u20131003.","journal-title":"Eur Heart J"},{"issue":"1","key":"914_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","volume":"55","author":"F Soriguer","year":"2012","unstructured":"Soriguer F, Goday A, Bosch-Comas A, Bordi\u00fa E, Calle-Pascual A, Carmena R, Casamitjana R, Casta\u00f1o L, Castell C, Catal\u00e1 M, Delgado E, Franch J, Gaztambide S, Girb\u00e9s J, Gomis R, Guti\u00e9rrez G, L\u00f3pez-Alba A, Mart\u00ednez-Larrad MT, Men\u00e9ndez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Mart\u00ednez G, Serrano-Rios M, Vald\u00e9s S, V\u00e1zquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study. Diabetologia. 2012 Jan;55(1):88\u201393.","journal-title":"Diabetologia"},{"key":"914_CR22","unstructured":"National Institute of Statistics, Spain. \n                    http:\/\/www.ine.es\/dyngs\/INEbase\/es\/categoria.htm?c=Estadistica_P&cid=1254735573175\n                    \n                  ."},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","volume":"56","author":"P Greenland","year":"2010","unstructured":"Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW, American College of Cardiology Foundation; American Heart Association. 2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2010;56:e50\u2013103.","journal-title":"J Am Coll Cardiol"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Ryd\u00e9n L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of diabetes (EASD). Eur Heart J. 2013;34:3035\u201387.","journal-title":"Eur Heart J"},{"key":"914_CR25","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.jacc.2016.08.070","volume":"68","author":"MO Gore","year":"2016","unstructured":"Gore MO, McGuire DK. A test in context: hemoglobin a(1c) and cardiovascular disease. J Am Coll Cardiol. 2016;68:2479\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"914_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/dom.13033","volume":"20","author":"R Roussel","year":"2018","unstructured":"Roussel R, Steg PG, Mohammedi K, Marre M, Potier L. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: a perspective on glucose-lowering interventions. Diabetes Obes Metab. 2018;20:238\u201344.","journal-title":"Diabetes Obes Metab"},{"key":"914_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2337\/dc13-1525","volume":"37","author":"W Zhao","year":"2014","unstructured":"Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and coronary heart disease risk among diabetic patients. Diabetes Care. 2014;37:428\u201335.","journal-title":"Diabetes Care"},{"key":"914_CR28","doi-asserted-by":"publisher","first-page":"e0123116","DOI":"10.1371\/journal.pone.0123116","volume":"10","author":"YY Chen","year":"2015","unstructured":"Chen YY, Lin YJ, Chong E, Chen PC, Chao TF, Chen SA, Chien KL. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan. PLoS One. 2015;10:e0123116.","journal-title":"PLoS One"},{"key":"914_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","volume":"375","author":"CJ Currie","year":"2010","unstructured":"Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481\u20139.","journal-title":"Lancet"},{"key":"914_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2796.2010.02265.x","volume":"268","author":"K Eeg-Olofsson","year":"2010","unstructured":"Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbj\u00f6rnsd\u00f3ttir S, Eliasson B. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med. 2010;268:471\u201382.","journal-title":"J Intern Med"},{"issue":"Suppl 1","key":"914_CR31","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.2337\/dc18-S009","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S86\u2013S104.","journal-title":"Diabetes Care"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0914-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0914-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0914-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T02:36:48Z","timestamp":1569379008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0914-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0914-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"21 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was aproved by the \u201c(CEIC de la Direcci\u00f3n General de Salud P\u00fablica y Centro Superior de Investigaci\u00f3n en Salud P\u00fablica at March 14th, 2008 14 de marzo del a\u00f1o 2.008)\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"180"}}